These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 19398708)

  • 1. Altered anandamide degradation in attention-deficit/hyperactivity disorder.
    Centonze D; Bari M; Di Michele B; Rossi S; Gasperi V; Pasini A; Battista N; Bernardi G; Curatolo P; Maccarrone M
    Neurology; 2009 Apr; 72(17):1526-7. PubMed ID: 19398708
    [No Abstract]   [Full Text] [Related]  

  • 2. Endocannabinoids activate transient receptor potential vanilloid 1 receptors to reduce hyperdopaminergia-related hyperactivity: therapeutic implications.
    Tzavara ET; Li DL; Moutsimilli L; Bisogno T; Di Marzo V; Phebus LA; Nomikos GG; Giros B
    Biol Psychiatry; 2006 Mar; 59(6):508-15. PubMed ID: 16199010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and isolation of anandamide and other endocannabinoids.
    Hanus LO
    Chem Biodivers; 2007 Aug; 4(8):1828-41. PubMed ID: 17712821
    [No Abstract]   [Full Text] [Related]  

  • 4. Quantitative method for the profiling of the endocannabinoid metabolome by LC-atmospheric pressure chemical ionization-MS.
    Williams J; Wood J; Pandarinathan L; Karanian DA; Bahr BA; Vouros P; Makriyannis A
    Anal Chem; 2007 Aug; 79(15):5582-93. PubMed ID: 17600384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FAAH and anandamide: is 2-AG really the odd one out?
    Di Marzo V; Maccarrone M
    Trends Pharmacol Sci; 2008 May; 29(5):229-33. PubMed ID: 18394720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allergen challenge increases anandamide in bronchoalveolar fluid of patients with allergic asthma.
    Zoerner AA; Stichtenoth DO; Engeli S; Batkai S; Winkler C; Schaumann F; Janke J; Holz O; Krug N; Tsikas D; Jordan J; Hohlfeld JM
    Clin Pharmacol Ther; 2011 Sep; 90(3):388-91. PubMed ID: 21716266
    [No Abstract]   [Full Text] [Related]  

  • 7. The endovanilloid/endocannabinoid system in human osteoclasts: possible involvement in bone formation and resorption.
    Rossi F; Siniscalco D; Luongo L; De Petrocellis L; Bellini G; Petrosino S; Torella M; Santoro C; Nobili B; Perrotta S; Di Marzo V; Maione S
    Bone; 2009 Mar; 44(3):476-84. PubMed ID: 19059369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of endocannabinoid synthesis and degradation in the uterus during embryo implantation.
    Wang H; Xie H; Sun X; Kingsley PJ; Marnett LJ; Cravatt BF; Dey SK
    Prostaglandins Other Lipid Mediat; 2007 Feb; 83(1-2):62-74. PubMed ID: 17259073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease.
    Dowie MJ; Bradshaw HB; Howard ML; Nicholson LF; Faull RL; Hannan AJ; Glass M
    Neuroscience; 2009 Sep; 163(1):456-65. PubMed ID: 19524019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for the intracellular accumulation of anandamide in adiposomes.
    Oddi S; Fezza F; Pasquariello N; De Simone C; Rapino C; Dainese E; Finazzi-Agrò A; Maccarrone M
    Cell Mol Life Sci; 2008 Mar; 65(5):840-50. PubMed ID: 18213445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol.
    Spoto B; Fezza F; Parlongo G; Battista N; Sgro' E; Gasperi V; Zoccali C; Maccarrone M
    Biochimie; 2006 Dec; 88(12):1889-97. PubMed ID: 16949718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anxiolytic-like properties of the anandamide transport inhibitor AM404.
    Bortolato M; Campolongo P; Mangieri RA; Scattoni ML; Frau R; Trezza V; La Rana G; Russo R; Calignano A; Gessa GL; Cuomo V; Piomelli D
    Neuropsychopharmacology; 2006 Dec; 31(12):2652-9. PubMed ID: 16541083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organized trafficking of anandamide and related lipids.
    Yates ML; Barker EL
    Vitam Horm; 2009; 81():25-53. PubMed ID: 19647107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the endocannabinoid system in human spermatozoa and involvement of transient receptor potential vanilloid 1 receptor in their fertilizing ability.
    Francavilla F; Battista N; Barbonetti A; Vassallo MR; Rapino C; Antonangelo C; Pasquariello N; Catanzaro G; Barboni B; Maccarrone M
    Endocrinology; 2009 Oct; 150(10):4692-700. PubMed ID: 19608651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cannabinoid system and its pharmacological manipulation--a review, with emphasis upon the uptake and hydrolysis of anandamide.
    Fowler CJ
    Fundam Clin Pharmacol; 2006 Dec; 20(6):549-62. PubMed ID: 17109648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocannabinoids: synthesis and degradation.
    Di Marzo V
    Rev Physiol Biochem Pharmacol; 2008; 160():1-24. PubMed ID: 18481028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anandamide: an update.
    Smita K; Sushil Kumar V; Premendran JS
    Fundam Clin Pharmacol; 2007 Feb; 21(1):1-8. PubMed ID: 17227440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocannabinoid system and nitric oxide are involved in the deleterious effects of lipopolysaccharide on murine decidua.
    Vercelli CA; Aisemberg J; Billi S; Wolfson ML; Franchi AM
    Placenta; 2009 Jul; 30(7):579-84. PubMed ID: 19428101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biosynthetic pathways of the endocannabinoid anandamide.
    Okamoto Y; Wang J; Morishita J; Ueda N
    Chem Biodivers; 2007 Aug; 4(8):1842-57. PubMed ID: 17712822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anandamide and the vanilloid receptor (TRPV1).
    Tóth A; Blumberg PM; Boczán J
    Vitam Horm; 2009; 81():389-419. PubMed ID: 19647120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.